Research Article

Accuracy of the national institute for neurological disorders and stroke/society for progressive supranuclear palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy

  1. Gesine Respondek MD1,2,3,
  2. Sigrun Roeber MD4,
  3. Hans Kretzschmar MD4,
  4. Claire Troakes PhD5,
  5. Safa Al-Sarraj FRCPath5,
  6. Ellen Gelpi MD6,
  7. Carles Gaig MD6,
  8. Wang Zheng Chiu MD7,
  9. John C. van Swieten MD7,
  10. Wolfgang H. Oertel MD1,
  11. Günter U. Höglinger MD1,2,3,*

Article first published online: 21 FEB 2013

DOI: 10.1002/mds.25327

Issue

Movement Disorders

Movement Disorders

Volume 28, Issue 4, pages 504–509, April 2013

Additional Information

How to Cite

Respondek, G., Roeber, S., Kretzschmar, H., Troakes, C., Al-Sarraj, S., Gelpi, E., Gaig, C., Chiu, W. Z., van Swieten, J. C., Oertel, W. H. and Höglinger, G. U. (2013), Accuracy of the national institute for neurological disorders and stroke/society for progressive supranuclear palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy. Mov. Disord., 28: 504–509. doi: 10.1002/mds.25327

Author Information

  1. 1

    Department of Neurology, Philipps Universität, Marburg, Germany

  2. 2

    Department of Neurology, Technische Universität München, Munich, Germany

  3. 3

    German Center for Neurodegenerative Diseases, Munich, Germany

  4. 4

    Center for Neuropathology and Prion Research, Ludwig Maximilians University, Munich, Germany

  5. 5

    Medical Research Council London Neurodegenerative Diseases Brain Bank, King's College, London, UK

  6. 6

    Neurological Tissue Bank and Neurology Department, Hospital Clinic/Institut d'Investigacio Biomedica August Pi i Sunyer, Barcelona, Spain

  7. 7

    Department of Neurology, Erasmus Medical Center, Rotterdam, The Netherlands

*Correspondence to: Dr. Günter U. Höglinger, Department of Translational Neurodegeneration, German Center for Neurodegenerative Diseases, München, Max Lebsche Platz 30, D-81677 Munich, Germany; guenter.hoeglinger@dzne.de

  1. Relevant conflicts of interest/financial disclosures: G.U.H. is supported by the Deutsche Forschungsgemeinschaft (HO2402/6-1). E.G. is partially funded by the Spanish Ministerio de Economia y Competitividad, Programa de Técnicos de Apoyo 2011, and received a research grant from the Academia de Ciencies Mediques de Catalunya 2011.

  2. Full financial disclosures and author roles may be found in the online version of this artcle.

Publication History

  1. Issue published online: 8 APR 2013
  2. Article first published online: 21 FEB 2013
  3. Manuscript Accepted: 26 NOV 2012
  4. Manuscript Revised: 31 OCT 2012
  5. Manuscript Received: 3 JUL 2012

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS